Clinical Trial Update: MERITnI - Mindray-hs-cTnI Assay: Analytical and Clinical Evaluation for the Diagnosis and RIsk AssessmenT of Myocardial InfarctIon.

View source ↗

Summary

Clinical trial update for the MERITnI study evaluating the Mindray hs-cTnI assay for diagnosing and risk-stratifying acute myocardial infarction, with active_no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• Mindray hs-cTnI assay

Snippet

Sponsor: Hennepin Healthcare Research Institute | Conditions: Acute Myocardial Infarction, Acute Coronary Syndrome | Status: ACTIVE_NOT_RECRUITING